Numinus has announced a bought deal public offering, with 24m units priced at $1.25 each, for aggregate gross proceeds of $30m. Full news release… THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, March 15, 2021 (GLOBE NEWSWIRE) — Numinus Wellness…


Previous articlePsychedelic Bulletin: Harvard Revisits Psychedelics; MindMed Attracts Strategic Investor; Psychedelics Companies Shed Cannabis Assets
Next articleBright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows an Over 50% Decrease in Opioid Self-Administration in a Predictive Rodent Model